Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A

Adv Exp Med Biol. 2002;506(Pt B):761-9. doi: 10.1007/978-1-4615-0717-8_107.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Conjunctiva / immunology
  • Conjunctiva / pathology
  • Cyclosporine / administration & dosage*
  • Double-Blind Method
  • Drug Administration Schedule
  • Epithelial Cells / immunology
  • Flow Cytometry
  • HLA-DR Antigens / analysis*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Keratoconjunctivitis Sicca / drug therapy*
  • Keratoconjunctivitis Sicca / immunology*
  • Keratoconjunctivitis Sicca / pathology
  • Middle Aged

Substances

  • HLA-DR Antigens
  • Immunosuppressive Agents
  • Cyclosporine